Most influenza vaccine platforms use hemagglutinin (HA) and/or neuraminidase (NA) as vaccine antigens to elicit immune responses that will interfere with the HA and NA activity during viral infection [15,16,17,18]. This evidence concerns the gene XK and influenza.